Skip to main content
    C

    Compass Therapeutics Inc. (CMPX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.61
    -0.05 (-8.28%)

    Market Cap: $139.35M

    Last updated: Nov 17, 2026 at 4:38 PM ET

    Compass Therapeutics Inc. (CMPX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Compass Therapeutics (CMPX) has a market cap of $139.35M and an enterprise value of $97.88M. Its share count is up 10.67% from a year earlier. It holds $41.47M more cash than debt, 29.76% of its market cap.

    Total Valuation

    Enterprise value is 29.76% below the market cap, as cash exceeds debt.

    Market Cap$139.35M
    Enterprise Value$97.88M
    Latest price (Nov 17, 2026)$0.61

    Key Dates

    The next earnings report is expected on Mar 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 3, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 16.52% a year over 2 years.

    Shares Outstanding186.80M
    Shares Change (YoY)+10.67%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+16.52%

    Price Statistics

    The stock is down 87.44% over 52 weeks and trades 42.99% below its 50-day average.

    Beta (1Y)1.75
    52-Week Change-87.44%
    1-Month Change-27.34%
    3-Month Change-75.54%
    6-Month Change-66.48%
    5-Year Change-73.96%
    Total Return (1Y)-87.44%
    Total Return (3Y CAGR)-27.46%
    Total Return (5Y CAGR)-30.99%
    Max Drawdown (1Y)-90.93%
    Max Drawdown (3Y)-90.93%
    Sharpe Ratio (1Y)-1.64
    Correlation with SPY (1Y)0.19
    50-Day Average$1.07
    200-Day Average$2.87
    52-Week Range$0.66 to $6.88
    RSI (14 Days)27.1
    Average Volume (20 Days)2.07M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 6.79x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio6.79x
    Quick Ratio6.79x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -60.57% over the last 12 months, against a 5-year average of -36.42%.

    Return on Equity (ROE)-60.57%
    Return on Assets (ROA)-49.49%
    Return on Capital Employed (ROCE)-57.52%
    ROE (5Y Average)-36.42%
    ROA (5Y Average)-33.13%
    ROIC (5Y Average)-26.69%

    Scores

    CMPX has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Gross Profit-$370.00K
    Operating Income-$94.07M
    Pretax Income-$86.36M
    Net Income-$86.36M
    EBIT-$86.36M
    Reported EPS (TTM)-$0.47

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 81.70% of the $174.50M in total assets.

    Cash and Equivalents$41.47M
    Total Debt$0
    Net Cash$41.47M
    Net Cash Per Share$0.22
    Working Capital$141.13M
    Shareholder Equity$142.57M
    Book Value Per Share$0.76
    Total Assets$174.50M
    Total Liabilities$31.93M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $364.00K of capital spending, operating cash flow left -$61.94M of free cash flow.

    Operating Cash Flow-$61.58M
    Capital Expenditures$364.00K
    Free Cash Flow-$61.94M
    FCF Per Share-$0.34
    Depreciation and Amortization$1.67M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-4.34%
    Tangible Book Per Share Growth (2Y CAGR)-4.34%

    Revenue and profit by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About CMPX

    What is CMPX's market cap?

    Compass Therapeutics has a market cap of $139.35M. Its enterprise value, which adds debt and subtracts cash, is $97.88M.

    How many shares of CMPX are outstanding?

    Compass Therapeutics has 186.80M shares outstanding. The count is up 10.67% from a year earlier.

    Does CMPX pay a dividend?

    No. Compass Therapeutics does not pay a dividend.

    How much debt does CMPX have?

    Compass Therapeutics has $0 of total debt and $41.47M of cash and equivalents, a net cash position of $41.47M.